retatrutide triple agonist weight loss trial Medscape | Retatrutide, Eli Lilly's first-in-class hormone receptor agonist, delivered meaningful at 80 weeks in all doses in the Retatrutide Dosing Guide: 1-12 mg
Pay in 4 interest-free payments of $5.91 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1























